The extraneuronal disease of NPC1 is clinically significant, with hepatosplenomegaly and persistent liver disease, and even liver failure, documented in NPC1 patients (Kelly et al, 1993; Vanier, 2010; Patterson et al, 2013; Geberhiwot et al, 2018). The gene discussed is NPC1; the disease is Hepatosplenomegaly.